US Stock MarketDetailed Quotes
MDNAF Medicenna Therapeutics
- 1.129
- +0.072+6.81%
15min DelayClose Nov 22 16:00 ET
86.29MMarket Cap-4150P/E (TTM)
1.129High1.060Low105.76KVolume1.090Open1.057Pre Close115.71KTurnover0.47%Turnover RatioLossP/E (Static)76.43MShares2.20052wk High5.28P/B25.29MFloat Cap0.28452wk Low--Dividend TTM22.40MShs Float6.840Historical High--Div YieldTTM6.53%Amplitude0.151Historical Low1.094Avg Price1Lot Size
Medicenna Therapeutics Key Stats
EPS
According to the latest financial report of Medicenna Therapeutics, the latest earnings per share (TTM) for the company is -0.05. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CAD
Quarterly
Loading...
FCF
Interested in knowing about Medicenna Therapeutics's free cash flow? The latest report shows it as -2.36M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: CAD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Medicenna Therapeutics shows that the company's current ratio is 9.43, indicating healthy liquidity.
Currency: CAD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Medicenna Therapeutics, the quick ratio is 9.15, indicating that the company can meet its short-term debt obligations.
Currency: CAD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Medicenna Therapeutics? The latest ROE figure is -25.91%, indicating that the company has stable profitability.
Currency: CAD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Medicenna Therapeutics, the total asset return on investment (ROA) is -12.73%.
Currency: CAD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Medicenna Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: CAD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Medicenna Therapeutics, the net profit margin is --, which is a good sign for its profitability.
Currency: CAD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data